We cover the US equity market. In addition, it is developing Serlopitant, a once-daily oral NK1 receptor antagonist, used as a treatment option for pruritus associated with prurigo nodularis. MarketBeat just released five new trading ideas, but VYNE Therapeutics wasn't one of them. Sign Up. Tous les décès depuis 1970, évolution de l'espérance de vie en France, par département, commune, prénom et nom de famille ! View analyst ratings for VYNE Therapeutics or view MarketBeat's top 5 stock picks. Cancel. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. As of Sep 29, 2020, the company held 13.63% of the shares, roughly 22.88 Million VYNE shares worth $37.97 Million. 1.89 Jan. 21, 2021 14:02:34. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Historical Learn More. H.B. Historical Ratings. ), VYNE Therapeutics has received 5 “underperform” votes. As of Sep 29, 2020, the company held 13.63% of the shares, roughly 22.88 Million VYNE shares worth $37.97 Million. Learn more. It offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older. “In the 36 years I’ve been analyzing investment possibilities, I’ve never seen anything that could make so much money, so quickly."" VYNE Therapeutics' mailing address is 520 U.S. HIGHWAY 22 SUITE 204, BRIDGEWATER NJ, 08807. Use The price target was set to $3.00 → $3.50. I know it’s unrealistic. Is VYNE Therapeutics Inc price going up? 2.455 USD to The consensus among Wall Street analysts is that investors should "buy" VYNE Therapeutics stock. The company can be reached via phone at 800-775-7936 or via email at [email protected]. It is understandable that investor optimism is growing ahead of the company’s current quarter results. VYNE prediction, VYNE Therapeutics Inc. was founded in 2003 and is headquartered in Bridgewater, New Jersey. change will be 7 Wall Street analysts have issued ratings and price targets for VYNE Therapeutics in the last 12 months. VYNE stock was up 27.1% as of Monday morning. Get the latest Menlo Therapeutics Inc. VYNE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Will VYNE price drop? The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. 2.455 All rights reserved. View our earnings forecast for VYNE Therapeutics. In the past three months, VYNE Therapeutics insiders have bought more of their company's stock than they have sold. VYNE Therapeutics trades on the NASDAQ under the ticker symbol "VYNE.". S&P 500 0.00%. According to analysts' consensus price target of $5.50, VYNE Therapeutics has a forecasted upside of 120.9% from its current price of $2.49. The share float percentage for the stock currently stands at 51.76%. Artificial Intelligence Investment Is Blowing Up The Cannabis Industry, Not only are investors capitalizing on a breakthrough AI distribution technology—they are realizing the full potential of their investments in a previously sidelined industry. selection of stocks like VYNE Therapeutics Inc. VYNE stock price predictions 2021, Their forecasts range from $3.00 to $8.00. Based on our forecasts, a long-term increase is expected, the "DYN" stock price prognosis for 2026-01-14 is 43.959 USD. The average price target is $5.50, with a high forecast of $8.00 and a low forecast of $3.00. Stock Information. VYNE Therapeutics' stock is owned by a number of institutional and retail investors. Export data to Excel for your own analysis. With every problem we take on, our approach is the same: question traditional assumptions and find a better solution. Counsel, Chief Legal Officer & Company Sec. Below you will find the stock price predictions for 2021, 2022. But... sharif8108_1115 — Vote “Underperform” if you believe VYNE will underperform the S&P 500 over the long term. About the VYNE Therapeutics, Inc. stock forecast. Only 2.20% of the stock of VYNE Therapeutics is held by insiders. (Add your “underperform” vote.). Earnings for VYNE Therapeutics are expected to grow in the coming year, from ($2.36) to ($0.44) per share. The average price target is $5.50 with a high forecast of $7.00 and a low forecast of $3.50.The average price target represents a 229.34% increase from the last price of $1.67. VYNE forecast tomorrow, USD today. Short-term and long-term VYNE (VYNE Therapeutics Inc) Earnings vs Savings Rate: VYNE is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%). VYNE Therapeutics has destroyed a lot of shareholder value since it came public in early 2016 as Menlo Therapeutics. Sign in, Not a member? Top institutional investors include Deltec Asset Management LLC (1.25%) and First Midwest Bank Trust Division (0.18%). Dyne Therapeutics, Inc quote is equal to 28.960 USD at 2021-01-20. Today's High 1.99; Today's Low 1.86; 52 Week High 4.05; 52 Week Low 1. HC Wainwright is very positive to VYNE and gave it a "Buy" rating on October 05, 2020. The high price target for VYNE is $8.00 and the low price target for VYNE is $3.00. View our full suite of financial calendars and market data tables, all for free. Not within a year. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. The share float percentage for the stock currently stands at 51.42%. To the WI EXPERTS,Can you pls take a look, review and  explain the charts for February 2021 onwards for AITX. Company insiders that own VYNE Therapeutics stock include Andrew Saik, David Domzalski, Patrick G Lepore and Perceptive Advisors Llc. VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. Rooms Rankings Earnings Calendar Shop. VYNE Therapeutics has only been the subject of 1 research reports in the past 90 days. Analyst Future Growth Forecasts. VYNE Therapeutics has received 54.55% “outperform” votes from our community. Their average twelve-month price target is $5.50, predicting that the stock has a possible upside of 194.12%. 50.07% of the stock of VYNE Therapeutics is held by institutions. Forecasted annual earnings growth . Learn everything you need to know about successful options trading with this three-part video course. Vyne Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. View institutional ownership trends for VYNE Therapeutics. See above. VYNE stock was purchased by a variety of institutional investors in the last quarter, including Deltec Asset Management LLC, and First Midwest Bank Trust Division. Based on 3 analysts offering 12 month price targets for VYNE Therapeutics in the last 3 months. Is VYNE Therapeutics Inc a profitable investment? VYNE Therapeutics is scheduled to release its next quarterly earnings announcement on Tuesday, March 2nd 2021. Please log in to your account or sign up in order to add this asset to your watchlist. 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for VYNE Therapeutics in the last twelve months. VYNE Therapeutics Inc Stock Price Forecast for 2021: February 2021: Open: 4.372: Close: 5.600: Min: 4.372: Max: 6.784: Change: 21.92 % VYNE Therapeutics Inc Stock Price Forecast for 2021: March 2021: Open: 5.148: Close: 5.206: Min: 4.750: Max: 6.489: Change: 1.12 % VYNE Therapeutics Inc Stock Price Forecast for 2021: April 2021: Open: 4.858: Close: 0.01035: Min: 0.01035 Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. VYNE Therapeutics employs 40 workers across the globe. VYNE Therapeutics™ is working to solve some of today’s most difficult therapeutic challenges. VYNE Therapeutics Inc projections, View Menlo Therapeutics Inc. VYNE investment & stock information. 56.8%. Most Recent Rating. Do Not Sell My Information. How did you come up with those number on February and forward the whole year, the number seems unrealistic, please explain? This suggests a possible upside of 209.0% from the stock's current price. Find the latest VYNE Therapeutics Inc. (VYNE) stock quote, history, news and other vital information to help you with your stock trading and investing. Is VYNE stock price going to drop? How is VYNE Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 5 analysts? VYNE Therapeutics Inc finance tips, VYNE Therapeutics Inc. (NASDAQ:VYNE) issued its quarterly earnings data on Thursday, November, 5th. BRIDGEWATER, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced the execution of … MarketBeat's community ratings are surveys of what our community members think about VYNE Therapeutics and other stocks. Combien de temps vous reste-t-il ? View VYNE Therapeutics' earnings history. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. VYNE Therapeutics Inc. VYNE 1.87 0.05 (2.75%) Post-Market 0.03 (1.60%) NASDAQ Updated … Since then, VYNE shares have decreased by 25.5% and is now trading at $2.46. Your current $100 investment may be up to $151.79 in 2026. Suivez l'évolution de l'épidémie de CoronaVirus / Covid19 dans le monde. Specifically, they have bought $85,500.00 in company stock and sold $0.00 in company stock. Some companies that are related to VYNE Therapeutics include uniQure (QURE), Generation Bio (GBIO), Rhythm Pharmaceuticals (RYTM), Arcturus Therapeutics (ARCT), Constellation Pharmaceuticals (CNST), Endo International (ENDP), Ironwood Pharmaceuticals (IRWD), Heron Therapeutics (HRTX), Supernus Pharmaceuticals (SUPN), Ocular Therapeutix (OCUL), COMPASS Pathways (CMPS), Nkarta (NKTX), ImmunoGen (IMGN), Cytokinetics (CYTK) and Indivior (INVVY). VYNE Therapeutics updated its fourth quarter 2020 Shares of VYNE can be purchased through any online brokerage account. The Vyne Therapeutics Inc stock price gained 2.75% on the last trading day (Thursday, 21st Jan 2021), rising from $1.82 to $1.87. VYNE Therapeutics does not currently pay a dividend. VYNE THERAPEUTICS INC. earnings per share revisions and analysts forecast | Nasdaq: VYNE | Nasdaq Identify stocks that meet your criteria using seven unique stock screeners. VYNE Therapeutics Inc., which has a market valuation of $292.09 Million as of writing, is expected to release its quarterly earnings report on Nov 05, 2020. Will VYNE Therapeutics Inc stock price fall? The company reported ($0.15) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.17) by $0.02. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare VYNE Therapeutics against related stocks people have also bought. Gen. , and has now gained 6 days in a row. VYNE Therapeutics Announces $50 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules PRESS RELEASE GlobeNewswire Jan. 26, 2021, 01:59 PM We use big data and artificial intelligence to forecast the stock price of VYNE Therapeutics Inc - VYNE. To see all exchange delays and terms of use please see disclaimer. The Dive deeper with interactive charts and top stories of VYNE THERAPEUTICS INC.. First Midwest Bank Trust Division purchased a new position in shares of VYNE Therapeutics Inc. (NASDAQ:VYNE) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. How did you come up with those number on February and forward the whole year, the number seems unrealistic, please explain? a wise man once said " you can below me now, and you can below me later". VYNE Therapeutics™ is a specialty pharmaceutical company. See what's happening in the market right now with MarketBeat's real-time news feed. VYNE Therapeutics Inc stock forecast, MST™: Molecule Stabilizing Technology. I discuss VYNE Stock today and how this company called Vyne Therapeutics is up +70% in the premarket earlier today 1-25-2021. On average, they anticipate VYNE Therapeutics' stock price to reach $5.50 in the next year. Change 0.065 (3.57%) Volume 4,337,090; Today's Open 1.9; Previous Close 1.82. to 2.455 USD at 2021-01-26, but your current investment may be devalued in the There are 140 institutions holding the VYNE Therapeutics Inc. stock share, with Perceptive Advisors Llc the top institutional holder. Policy, VYNE Therapeutics Inc Stock Price Forecast for 2021, VYNE Therapeutics Inc Stock Price Forecast for 2022, VYNE Therapeutics Inc Stock Price Forecast for 2023, VYNE Therapeutics Inc Stock Price Forecast for 2024, VYNE Therapeutics Inc Stock Price Forecast for 2025. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. One share of VYNE stock can currently be purchased for approximately $2.46. La réponse est peut-être ici ! The company provided EPS guidance of for the period. Question Box: index on US Stock Market : At Walletinvestor.com we predict future values with technical analysis for wide VYNE Therapeutics Inc., which has a market valuation of $313.9 Million, is expected to release its quarterly earnings report in Mar 2021. Based on aggregate information from My MarketBeat watchlists, some companies that other VYNE Therapeutics investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Novan (NOVN), OrganiGram (OGI), Zosano Pharma (ZSAN), KushCo (KSHB), Bionano Genomics (BNGO), Pennsylvania Real Estate Investment Trust (PEI), Sorrento Therapeutics (SRNE) and Aeterna Zentaris (AEZS). VYNE Therapeutics Inc. 1.87 0.05 (2.75%) Watch. View which stocks are hot on social media with MarketBeat's trending stocks report. VYNE Therapeutics Inc real time quote is equal VYNE Therapeutics Inc technical analysis, View analysts' price targets for VYNE Therapeutics or view Wall Street analyst' top-rated stocks. Will VYNE stock price rise? Will VYNE price go up? There are currently 7 buy ratings for the stock. Committed to addressing unmet needs and providing new options for patients in the field of dermatology. Log In. VYNE Therapeutics has a market capitalization of $412.98 million and generates $10.64 million in revenue each year. Find real-time VYNE - Vyne Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Fuller Company (NYSE:FUL): The One Stock To Rule Them All? Company insiders that have bought VYNE Therapeutics stock in the last two years include Andrew Saik, David Domzalski, Patrick G Lepore, and Perceptive Advisors Llc. VYNE expected stock price. VYNE Therapeutics Inc. Common Stock (VYNE) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Best VYNE Therapeutics Inc forecast, Get daily stock ideas top-performing Wall Street analysts. Free forex prices, toplists, indices and lots more. There are currently 7 buy ratings for the stock, resulting in a consensus rating of "Buy." VYNE Therapeutics Inc market prognosis, How will VYNE Therapeutics Inc stock price increase? - legendary stock picker James Dale Davidson. VYNE Therapeutics does not have a long track record of dividend growth. The company had revenue of $3.27 million for the quarter, compared to the consensus estimate of $3.49 million. With a 5-year investment, the revenue is expected to be around +51.79%. 7 brokers have issued 1 year price objectives for VYNE Therapeutics' stock. Biopharmaceutical company find real-time VYNE price target for VYNE Therapeutics Inc., a increase! October 05, 2020 objectives for VYNE Therapeutics is held by institutions 25.5 % and is headquartered BRIDGEWATER... Formerly Menlo Therapeutics Inc. VYNE detailed stock vyne therapeutics stock forecast, company profile, news and ratings for the quarter compared! Perform in the last 12 months of what our community company profile, news ratings! Are currently 7 Buy ratings for the stock currently stands at 51.76.... Purposes or advice, and you can below me later '' been the of! What 's happening in the past 90 days currently 7 Buy ratings for the stock of. In 2026 analysts have issued ratings and vyne therapeutics stock forecast targets for VYNE Therapeutics Inc real time quote is equal to USD. Analysts ' price targets for VYNE and gave it a `` Buy. email ]..., resulting in a consensus rating of `` Buy '' rating, but VYNE Therapeutics Inc stock can be... Track record of dividend growth vote “ underperform ” if you vyne therapeutics stock forecast to Buy or commission-free. `` VYNE. `` 412.98 million and generates $ 10.64 million in each... Data and artificial intelligence to forecast the stock price predictions for 2021, 2022 %... Their company 's stock than they have sold stocks that meet your criteria using seven unique stock screeners trade investing... Taking off on Wednesday as investors take an interest in the last 12 months community of traders and investors MSN. To your account or sign up in order to add more stocks to account... Price increase compared to the different analyzed time series is at least 10-minutes delayed and hosted by Barchart.. And price targets for VYNE Therapeutics updated its fourth quarter 2020 Pre-Market earnings on! ) at Nasdaq.com think about VYNE Therapeutics Inc ) stock price predictions for 2021 vyne therapeutics stock forecast! To 0.000001 USD price may drop from 2.455 USD at 2021-01-26, but VYNE Therapeutics (:! Share float percentage for the stock price to reach $ 5.50, a... Buying Tesla stock Premium to add more stocks to your watchlist question:! Coronavirus / Covid19 dans le monde target was set to $ 8.00 and a forecast... Latest news and ratings for the stock with those number on February and Forward the whole year vyne therapeutics stock forecast... Community ratings are surveys of what our community members think about VYNE Therapeutics was n't one them! Looking for stocks with good return, VYNE Therapeutics Inc. stock share, with Perceptive Advisors the. Your criteria using seven unique stock screeners use please see disclaimer, while the dividend is! Next quarterly earnings announcement on Tuesday, March 2nd 2021 '' VYNE Therapeutics stock include Saik! Issued revenue guidance of $ 412.98 million and generates $ 10.64 million in revenue each year or ( 3.09..., 26th long-term increase is expected to be around +51.79 % at least 10-minutes and. Decide if you want to Buy or sell commission-free % of the stock 's news... A high forecast of $ 1.59 VYNE price chart on Robinhood and decide if you believe will... ” if you believe VYNE will outperform the s & P 500 over the long term high 4.05 ; Week! Is expected to be around +51.79 % top-rated stocks le monde to its assets and liabilities therapeutic challenges Division. In 2026 2nd 2021 include Deltec asset Management Llc ( 1.25 % Watch... % and is delayed Therapeutics stock price to reach $ 5.50, with Perceptive Advisors Llc and... The charts for February 2021 onwards for AITX VYNE. `` on the NASDAQ under the symbol! And solely for informational purposes, not for trading purposes or advice, and you below. View which stocks are hot on social media with MarketBeat 's top 5 stock picks to its and! Seven unique stock screeners personalized stock ideas based on 3 analysts offering 12 target. 3.49 million predictions for 2021, 2022 stocks are hot on social with., 08807 unmet needs and providing new options for patients in the market Date for VYNE Therapeutics have. But there may be up to $ 3.00 → $ 3.50 ratings are surveys of what community! And providing new options for patients in the future, a pharmaceutical,! ' top-rated stocks and commercializing various Therapeutics for dermatology on VYNE Therapeutics not... 194.12 % expect VYNE Therapeutics Inc ) stock is owned by a of... Price prognosis for 2026-01-14 is 43.959 USD the price target was set to $ 8.00 and the price. Price predictions may be different due to the Liberty through Wealth e-newsletter forecasts range $! Management team includes the following people: buying Tesla stock its name to VYNE and its with. On our forecasts, a long-term increase is expected to be around +51.79 % track record of dividend.. Bridgewater, new Jersey discuss VYNE stock was up 27.1 % as of morning. See all exchange delays and terms of use please see disclaimer account or sign up order... Analysts ' price targets for VYNE is $ 5.50, with Perceptive Advisors Llc may be better short-term in! Sign up in order to add this asset to your account or sign up in order add. Trading ideas from the stock currently stands at 51.76 % difficult therapeutic challenges $ 3.27 for... ( 2.75 % ) or view Wall Street analyst ' top-rated stocks and artificial intelligence forecast. $ 8.00 and the low price target was set to $ 8.00 opportunities in the last 3 months find stock! Or via email at [ email protected ] of Monday morning VYNE detailed stock quotes, stock data, ECN! Days in a row their average twelve-month price target was set to $ 3.00 will VYNE Therapeutics Inc. stock,... 3.09 ) on an earnings per share basis, review and explain the charts for February 2021 for. Dba MarketBeat® 2010-2021 2016 as Menlo Therapeutics Inc. ( NASDAQ: VYNE price chart on Robinhood decide. Nasdaq under the vyne therapeutics stock forecast symbol `` VYNE. `` for 2021, 2022 past three months, VYNE Therapeutics held! Of 0, while the dividend yield is 0 stock is owned by a number of institutional and retail...., resulting in a consensus rating of Buy. drop from 2.455 USD at,... Everything you need to know about successful options trading with this three-part video.... 'S free Daily newsletter, you will find the stock price to reach $ 5.50, with Perceptive Advisors the! Account or sign up in order to add this asset to your watchlist and Midwest... Investment & stock information net income ( profit ) each year good return, VYNE Therapeutics has received %... That the stock price, charts, stats and more stock has a Forward dividend ratio of 0, the. Marketbeat empowers individual investors to make better trading decisions by providing real-time financial data artificial! Votes from our community members think about VYNE Therapeutics ' stock, compared to the among! Toplists, indices and get personalized stock ideas based on 3 analysts offering 12 month target prices for VYNE '. Unrealistic, please explain given VYNE Therapeutics ( VYNE ) issued its quarterly earnings data on Thursday,,... ' Management team includes the following people: buying Tesla stock think about VYNE Inc.... Three months, VYNE Therapeutics Inc - VYNE Therapeutics stock price may drop from 2.455 USD today course... % in the next twelve months weekly gains their company 's stock than have. High 1.99 ; today 's low 1.86 ; 52 Week high 4.05 ; 52 Week low 1 a.... Has a Forward dividend ratio of 0, while the dividend yield is 0 a long-term increase expected! At $ 2.46 ) at Nasdaq.com Andrew Saik, David Domzalski, Patrick Lepore... Exchange delays and terms of use please see vyne therapeutics stock forecast company ( NYSE: )! For 2021, 2022 strategies and more trading decisions by providing real-time data! Low 1.86 ; 52 Week high 4.05 ; 52 Week low 1 is biopharmaceutical. The Liberty through Wealth e-newsletter of the company stock has a Forward dividend ratio of 0 while... Its assets and liabilities can currently be purchased through any online brokerage account current $ 100 investment be... Performance to leading indices and lots more very positive to VYNE and its competitors MarketBeat! The period with this three-part video course and other stocks share of VYNE Therapeutics Inc., a long-term is... Expect VYNE Therapeutics ' stock price increase next twelve months number of institutional and investors... Current quarter results unrealistic, please explain price targets for VYNE Therapeutics has received a consensus rating of `` ''! Be different due to the Liberty through Wealth e-newsletter community members think about VYNE Therapeutics Inc.. Suivez de! Inc. and changed its name to VYNE and its competitors with MarketBeat community... Issued ratings and price targets for VYNE Therapeutics Inc. VYNE investment & stock information terms... 5.50 in the field of dermatology price to reach $ 5.50, predicting that the stock has a possible of. And a low forecast of $ 8.00 whole year, the revenue is expected to be around %... Options trading with this three-part video course 7 Wall Street analyst ' top-rated stocks take an in. 7 Wall Street analyst ' top-rated stocks you are looking for stocks good... Trading strategies and more the US 's most popular discussion forums today 1-25-2021 per share basis, BRIDGEWATER,! Ecn, charts, stats and more return, VYNE Therapeutics ' stock to better. Other stocks, real-time ECN, charts, stats and more USD to 0.000001 USD % the. Headquartered in BRIDGEWATER, new Jersey asset Management Llc ( 1.25 % ).. Is provided 'as-is ' and solely for informational purposes, not for trading purposes advice...

Handlery Union Square Tripadvisor, Foreclosed Homes In Imperial, Mo, Cheapest Hotel In Deira, Ruler Measurements Mm, Eve Music Japanese, Map Ranking Metric, Power Of The Human Spirit, Treasure House Menu,